Epilepsy Market Research Reports & Industry Analysis
Epilepsy Industry Research & Market Reports
-
The 2026-2031 World Outlook for Antiepileptic Therapeutics for Fibromyalgia
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
The 2026-2031 World Outlook for Epilepsy Monitoring Devices
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Acute Repetitive Seizures
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Epilepsy Drugs
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Anti-Epileptic Drugs
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Epilepsy Therapeutics
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Epilepsy Treatments
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
Global Infantile Spasms Therapeutics Market 2025-2029
... spasms therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Thailand Medical Cannabis Market Report by Cultivated Species (Indica, Sativa, Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), Application Areas (Cancer, Arthritis, Migraine, Epilepsy, and Others), End-Use (Pharmaceuticals, Research and Development Centres, and Others), Route of Administration (Oral Solutions and Capsules, Vaporizers, Topicals, and Others) 2025-2033
... The market is propelled by the favorable government regulatory framework, widespread acceptance of the product, rapid growth of cultivation facilities and production capacity, increasing research and development (R&D) activities by key players, rising international investments ... Read More
-
Epilepsy Drugs
... CAGR of 3.8% over the analysis period 2024-2030. First Generation, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$1.6 Billion by the end of the analysis ... Read More
-
Deep Brain Stimulation Devices
... 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Dual-Channel, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$1.7 Billion by the end ... Read More
-
Pediatric Epilepsy Therapeutics
... at a CAGR of 3.3% over the analysis period 2024-2030. Third Generation, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$7.0 Billion by the end of ... Read More
-
Global Dravet Syndrome Treatment Market 2025-2029
... syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Neuromodulation Market Report by Technology (Internal Neuromodulation, External Neuromodulation), Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials), Application (Parkinson's Disease, Epilepsy, Depression, Dystonia, Pain Management, and Others), and Region 2025-2033
... market is experiencing robust growth, driven by the increasing prevalence of chronic and neurological disorders, imposition of favorable regulatory environment, rising expenditure on healthcare, significant advancements in device technology, and growing demand for minimally invasive ... Read More
-
Global Epilepsy Drugs Market - 2025-2033
... CAGR of 4.2% during the forecast period 2025-2033. The global market for epilepsy drugs is gaining traction due to a mix of key developments. A growing number of antiepileptic drugs are receiving approval, while pharmaceutical ... Read More
-
Epilepsy Drugs Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Anticonvulsant Drugs Market, by Drug Class (Barbiturates, Benzodiazepines, Aromatic allylic alcohols, Carboxamides, Triazine, AMPA receptor antagonists, Carbamate, Hydantoin, Fatty Acid Derivative, GABA analogs, Valproylamides, Others (Propionates, Oxazolidinediones, etc.)), by Route of Administration (Enteral, Parenteral), by Indication (Epilepsy, Neuropathic pain, Anxiety, Fibromyalgia, Bipolar Disorder, Others (Borderline personality disorder, etc.)), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... borderline personality disorder. Anticonvulsants, including gabapentin, carbamazepine, and valproic acid, are believed to alleviate chronic pain by obstructing sodium (valproate and the gabapentanoids) or calcium (carbamazepine and Oxcarbazepine) channels at the cellular neuronal level. This ... Read More
-
Medical Foods Market Size, Share, and Outlook, 2025 Report- By Route of Administration (Oral, Enteral), By Product (Powder, Pills, Liquid, Other), By Application (Chronic Kidney Disease, Minimal Hepatic Encephalopathy, Chemotherapy Induced Diarrhea, Pathogen Related Infections, Diabetic Neuropathy, ADHD, Depression, Alzheimer's Disease, Nutritional Deficiency, Orphan Diseases, Wound Healing, Chronic Diarrhea, Constipation Relief, Protein Booster, Dysphagia, Pain Management, Parkinson's Disease, Epilepsy, Severe Protein Allergy, Cancer, Cachexia, Others), By Sales Channel (Online Sales, Retail Sales, Institutional Sales), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Medical Foods segments across 22 countries from 2021 to 2032. ... Read More
-
Medical Marijuana Market Size, Share, and Outlook, 2025 Report- By Product (Flower, Oil & Tinctures ), By Application (Cancer, Chronic Pain, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Post-Traumatic Stress Disorder (PTSD), Parkinson's Disease, Tourettes, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Medical Marijuana segments across 22 countries from 2021 to 2032. ... Read More
-
Neurology Clinical Trials Market Size, Share, and Outlook, 2025 Report- By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neurology Clinical Trials segments across 22 countries ... Read More
-
Global Neurotech Devices Market, By Product Type (Neurostimulation, Deep brain stimulator, Gastric electric stimulator, Spinal cord stimulator, Sacral nerve stimulator, Vagus nerve stimulator, Transcutaneous electrical nerve stimulation, Other neurostimulations, Neuroprostheses, Neurosensing, Neurorehabilitation devices), By Conditions (Pain management, Cognitive disorders, Epilepsy, Urinary and fecal incontinence, Hearing conditions, Parkinsons disease, Depression, Sleep disorders, Essential tremor, Other conditions), By End User (Hospitals, Ambulatory surgical centers, Homecare facilities, Other end users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... damaged pathways in the brain or spinal cord. Conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and chronic pain that have proved difficult to treat with conventional therapies may potentially benefit from targeted neuromodulation approaches. ... Read More
-
NEUROTECHNOLOGY MARKET - GROWTH, TRENDS, AND FORECASTS (2025 - 2030)
... are driving the growth of the neuroelectronics market include the increasing prevalence of neurological disorders, rapid advancements in neuroscience and technology, and the rising demand for improved treatment options. The rising incidence of neurological disorders, ... Read More
-
Acute Repetitive Seizures Market Size, Share & Trends Analysis Report 2025-2033
... 2025 to 2033. The acute repetitive seizures (ARS) market refers to the sector focused on the treatment and management of a neurological condition characterized by recurrent, yet distinct, episodes of seizures occurring within a short ... Read More
-
Neurodiagnostics Market, By Product Type (Electroencephalogram (EEG) Systems, Magnetic Resonance Imaging Systems, Ultrasound Imaging Systems, Computed Tomography Scanner, Reagents & Consumables, and Others), By Therapeutic Area (Neurodegenerative Diseases, Sleep Disorders, Stroke, Epilepsy, and Others), By End User (Hospitals, Diagnostic Centers, Ambulatory Care Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... growth over the past few years due to the rising incidence of neurological disorders such as Alzheimer's disease, Parkinson's disease, epilepsy, stroke, and various cancers affecting the nervous system. Advancements in neuroimaging technologies and development ... Read More
-
Epilepsy Drugs Market, By Type of Epilepsy (Focal Epilepsy, Generalized Epilepsy, Reflex Epilepsy, and Others (Progressive Myoclonic Epilepsy, etc.)), By Drugs (1st Generation, 2nd Generation, and 3rd Generation), By Route of Administration (Oral, Injectable, and Others (Nasal, etc.)), By Age Group (Pediatric, Adults, and Geriatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... in the brain causing seizures. It affects people of all ages but is more common in children and older adults. There is no cure for epilepsy but seizures can be controlled in about 70% of ... Read More
Research Assistance
